Abbott Alinity News Today

Discover how modern quality control (QC) principles can enhance operational efficiency and healthcare outcomes

Discover how modern quality control (QC) principles can enhance operational efficiency and healthcare outcomes

Biotech stocks offers the potential for significant returns driven by breakthrough discoveries and advancements in healthcare, agriculture, and other industries.

Background Although vaccination against SARS-CoV-2 is recommended prior to introducing anti-CD20 therapies, limited data are available regarding the evolution of post-vaccinal immunity. Methods This retrospective study compared anti-Spike antibody titres at 6 and 12 months from SARS-CoV-2 vaccination between patients vaccinated before switching to anti-CD20 (‘Switch’) and two control groups: (1) patients vaccinated under disease-modifying therapies (DMTs) other than fingolimod and anti-CD20 ...

Every year, an estimated 1.6 million to 3.8 million sports- and recreation-related concussions are seen, as noted by the Brain Injury Research Institute (BIRI), adding that, “During 2001-2005, children and youth ages 5-18 years accounted for 2.4 ...

Welcome to the MassDevice Fast Five medtech news podcast. Here’s what you need to know for today, August 8, 2023.

Abbott (NYSE: ABT) announced today that the FDA has cleared its advanced Alinity h-series hematology system.

Four of the most prevalent STIs. The poster can be read at https://microbix.com and a REDx®FLOQ® product format is also available. Point of Care Tests that can distinguish...

Microbix Biosystems Inc. announced that it is presenting results of its Quality Assessment Products for supporting the clinical use and accuracy of multiplex tests for four of the most prevalent...

This year is proving to be another important year for in vitro diagnostic (IVD) innovation. Here are five stories that caught our attention.